Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | APAF1 | O14727 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | BRD4 | O60885 | 14/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14707343 | 0.85 | ALDH1A1 (0.66) | RORCALDH1A1MAPTSMN1; SMN2KDM4E | |
| SCHEMBL9290317 | 0.81 | CYP1B1 (0.56) | ALDH1A1MAPTKDM4EMEN1KMT2A | |
| SCHEMBL9290283 | 0.81 | NPSR1 (0.52) | RORCALDH1A1MAPTSMN1; SMN2KDM4E | |
| SCHEMBL9290277 | 0.80 | KEAP1 (0.55) | RORCALDH1A1MAPTSMN1; SMN2KDM4E | |
| SCHEMBL9290284 | 0.80 | ALDH1A1 (0.47) | RORCALDH1A1MAPTSMN1; SMN2KDM4E | |
| SCHEMBL9290384 | 0.79 | MAPT (0.45) | RORCALDH1A1MAPTSMN1; SMN2KDM4E | |
| SCHEMBL12561339 | 0.79 | BRD4 (0.47) | ALDH1A1MAPTSMN1; SMN2KDM4EAPAF1 | |
| SCHEMBL12601548 | 0.77 | PKM (0.58) | ALDH1A1SMN1; SMN2KDM4EBRD4PKM | |
| SCHEMBL9290310 | 0.77 | ALDH1A1 (0.45) | RORCALDH1A1MAPTSMN1; SMN2KDM4E | |
| SCHEMBL12561275 | 0.77 | RORC (0.44) | RORCALDH1A1MAPTSMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8350054-B2 | Optical filter | ADEKA CORPORATION (JP) | 2013-01-08 | — | — | US | disclosed |
| US-8350054-B2 | Optical filter | ADEKA CORPORATION (JP) | 2013-01-08 | — | — | US | disclosed |
| EP-2458941-A1 | OPTICAL FILTER | Adeka Corporation (JP) | 2012-05-30 | — | — | EP | disclosed |
| US-20110152538-A1 | OPTICAL FILTER | ADEKA CORPORATION (JP) | 2011-06-23 | — | — | US | disclosed |
| US-20110152538-A1 | OPTICAL FILTER | ADEKA CORPORATION (JP) | 2011-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110152538-A1 | OPTICAL FILTER | C1R, CBR3, CBR1 | RORC 1641/4885ALDH1A1 776/4885MAPT 4299/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.